Hepatotoxicity and potential drug interaction with ledipasvir/sofosbuvir in HIV/HCV infected patients

被引：5
|
作者：
Tseng, Alice [1 ]
Wong, David K. [1 ]
机构：
[1] Univ Hlth Network, Immunodeficiency Clin, Toronto, ON, Canada
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 65卷 / 03期
关键词：
DILI; Hepatitis C virus; Ledipasvir; HIV; Drug interaction; HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C; LIVER-FAILURE; SOFOSBUVIR; LEDIPASVIR;
D O I：
10.1016/j.jhep.2016.05.015
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：651 / 653
页数：4
相关论文
共 50 条
  • [1] Sofosbuvir and ledipasvir for HIV/HCV co-infected patients
    Rosenthal, Elana S.
    Kottilil, Shyam
    Polis, Michael A.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (05) : 743 - 749
  • [2] Diabetes Mellitus in HIV/HCV Co-Infected Patients Treated with Ledipasvir and Sofosbuvir
    Bhatti, Zabeer
    Gill, Dalvir
    Virk, Jaswinder
    Sivalingam, Devamohan
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S1360 - S1360
  • [3] Ledipasvir/sofosbuvir for 6 weeks in HIV-infected patients with acute HCV infection
    Nelson, M.
    Bhagani, S.
    Hyland, R.
    Yun, C.
    Natha, M.
    Zheng, W.
    Brainard, D.
    McHutchinson, J.
    Jackson, A.
    Ingiliz, P.
    Lutz, T.
    Rockstroh, J.
    [J]. HIV MEDICINE, 2016, 17 : 7 - 7
  • [4] Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1
    Naggie, Susanna
    Cooper, Curtis
    Saag, Michael
    Workowski, Kimberly
    Ruane, Peter
    Towner, William J.
    Marks, Kristen
    Luetkemeyer, Anne
    Baden, Rachel P.
    Sax, Paul E.
    Gane, Edward
    Santana-Bagur, Jorge
    Stamm, Luisa M.
    Yang, Jenny C.
    German, Polina
    Dvory-Sobol, Hadas
    Ni, Liyun
    Pang, Phillip S.
    McHutchison, John G.
    Stedman, Catherine A. M.
    Morales-Ramirez, Javier O.
    Braeu, Norbert
    Jayaweera, Dushyantha
    Colson, Amy E.
    Tebas, Pablo
    Wong, David K.
    Dieterich, Douglas
    Sulkowski, Mark
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (08): : 705 - 713
  • [5] Ledipasvir/sofosbuvir for 12 weeks in patients co-infected with HCV and HIV-1
    Naggie, Susanna
    Cooper, Curtis
    Saag, Michael
    Yang, Jenny C.
    Stamm, Luisa M.
    Pang, Philip S.
    McHutchison, John G.
    Dieterich, Douglas
    Sulkowski, Mark S.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2015, 18
  • [6] Ledipasvir/sofosbuvir for 12 weeks in patients co-infected with HCV and HIV-1
    Bhagani, S.
    Naggie, S.
    Cooper, C.
    Saag, M.
    Yang, J.
    Stamm, L.
    Pang, P.
    McHutchison, J.
    Troke, P.
    Dieterich, D.
    Sulkowski, M.
    [J]. HIV MEDICINE, 2015, 16 : 31 - 31
  • [7] Sofosbuvir/Ledipasvir in the Treatment of Early HCV Infection in HIV-infected Men
    Fierer, Daniel S.
    El Sayed, Ahmed
    Palaniswami, Paari
    [J]. HEPATOLOGY, 2016, 64 : 992A - 992A
  • [8] Safety and Efficacy of Ledipasvir/Sofosbuvir on Hepatitis C Eradication in HCV/HIV Co-infected Patients
    He, Xiaoping
    Hopkins, Lynne
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1497 - S1498
  • [9] Pharmacokinetics of Once Daily Sofosbuvir or Ledipasvir/Sofosbuvir in HCV-Infected Adolescents
    Kirby, Brian
    German, Polina
    Kanwar, Bittoo
    Ni, Liyun
    Lakatos, Isobel
    Ling, John
    Mathias, Anita
    [J]. HEPATOLOGY, 2015, 62 : 1040A - 1041A
  • [10] Drug-drug interaction profile, including HIV ART, of the HCV fixed-dose combination tablet ledipasvir/sofosbuvir
    Marra, F.
    German, P.
    Pang, P.
    Fang, L.
    Chung, D.
    Mathias, A.
    Aizen, K.
    [J]. HIV MEDICINE, 2015, 16 : 35 - 35
12345